Hepatitis C is a blood-borne liver disease caused by the hepatitis C virus (HCV). HCV belongs to the Flaviviridae virus family and is a communicable disease spread primarily through direct contact with the blood or the bodily fluids of an infected individual, including sexual and mother-to-child transmission.
Hepatitis C infection normally does not produce signs or symptoms and, as such, most people who are infected do not know they have the disease. Approximately 15% of infected individuals are able to clear the virus and are free from associated complications.
The remaining 85% of individuals are at risk of chronic hepatitis and complications associated with chronic infection, such as scarring, liver cancer, and liver failure. An estimated 20-30% of chronic HCV patients go on to develop cirrhosis, while 1-5% will develop liver cancer.
Key Topics Covered:
1. FORECAST: HEPATITIS C
Viekira Pak (paritaprevir/ritonavir/ombitasvir + dasabuvir)
2. TREATMENT: HEPATITIS C
Disease Definition and Diagnosis
Current Treatment Options
Country Treatment Trees
Unmet Needs in Hepatitis C
3. EPIDEMIOLOGY: HEPATITIS C IN THE US, JAPAN, AND 5EU